Summary
Goldline Pharmaceutical share holding pattern reports the following shareholding: Goldline Pharmaceutical Total Promoters is at 57.29%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 5.16%, Domestic Institutional Investors at 7.53%, and Retail at 30.02%. This breakdown provides a quick snapshot of ownership distribution for Goldline Pharmaceutical share holding pattern in 2026-27.
Goldline Pharmaceutical FAQs
As of 06-2026, the promoter shareholding in Goldline Pharmaceutical stands at 57.29% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Goldline Pharmaceutical is 5.16% and 7.53% respectively.
The retail shareholding of the Goldline Pharmaceutical is 30.02%.
Changes in shareholding patterns of Goldline Pharmaceutical can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Goldline Pharmaceutical are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Goldline Pharmaceutical Associated Pages
